| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Dec 18, 2025 | Arcus Biosciences, Inc. | CEO | Sell | 37.5 | -54,691 | -2.43% | ✗ | $1.2M |
| Feb 27, 2025 | Feb 27, 2025 | Arcus Biosciences, Inc. | CEO | Buy | 72.5 | +19,800 | 0.78% | ✗ | $201.5K |
| Dec 15, 2024 | Dec 17, 2024 | Arcus Biosciences, Inc. | CEO | Sell | 40.0 | -37,882 | -1.57% | ✗ | $609.1K |
| Jun 15, 2024 | Jun 18, 2024 | Arcus Biosciences, Inc. | CEO | Sell | 47.5 | -12,670 | -0.32% | ✗ | $215K |
| Dec 18, 2023 | Dec 20, 2023 | Arcus Biosciences, Inc. | CEO | Sell | 42.5 | -27,705 | -0.71% | ✗ | $496.4K |
| Jun 16, 2023 | Jun 16, 2023 | Arcus Biosciences, Inc. | CEO | Sell | 47.5 | -8,762 | -0.22% | ✗ | $169.5K |
| Dec 16, 2022 | Dec 16, 2022 | Arcus Biosciences, Inc. | CEO | Sell | 45.0 | -13,043 | -0.35% | ✗ | $401.1K |
| Jun 16, 2022 | Jun 21, 2022 | Arcus Biosciences, Inc. | CEO | Sell | 47.5 | -8,854 | -0.24% | ✗ | $189.9K |
| Dec 16, 2021 | Dec 20, 2021 | Arcus Biosciences, Inc. | CEO | Sell | 47.5 | -5,242 | -0.13% | ✗ | $210.3K |
| Jun 16, 2021 | Jun 21, 2021 | Arcus Biosciences, Inc. | CEO | Sell | 47.5 | -8,831 | -0.22% | ✗ | $211K |
| Aug 7, 2020 | Aug 11, 2020 | Arcus Biosciences, Inc. | CEO | Buy | 85.0 | +43,705 | 1.04% | ✗ | $999.3K |
| Jun 5, 2019 | Jun 7, 2019 | Arcus Biosciences, Inc. | CEO | Buy | 72.5 | +21,738 | 0.52% | ✗ | $172.3K |
| Jun 3, 2019 | Jun 5, 2019 | Arcus Biosciences, Inc. | CEO | Buy | 75.0 | +41,540 | 0.58% | ✗ | $328.6K |
| Aug 27, 2018 | Aug 29, 2018 | Arcus Biosciences, Inc. | CEO | Buy | 67.5 | +18,607 | 0.45% | ✗ | $280.4K |
| Aug 22, 2018 | Aug 24, 2018 | Arcus Biosciences, Inc. | CEO | Buy | 65.0 | +9,289 | 0.23% | ✗ | $124.9K |
| Aug 17, 2018 | Aug 21, 2018 | Arcus Biosciences, Inc. | CEO | Buy | 65.0 | +8,891 | 0.22% | ✗ | $117.7K |
| Aug 14, 2018 | Aug 16, 2018 | Arcus Biosciences, Inc. | CEO | Buy | 75.0 | +28,401 | 0.70% | ✗ | $359.1K |
| Aug 9, 2018 | Aug 13, 2018 | Arcus Biosciences, Inc. | CEO | Buy | 65.0 | +9,929 | 0.24% | ✗ | $117.9K |
| Mar 19, 2018 | Mar 19, 2018 | Arcus Biosciences, Inc. | CEO | Buy | 85.0 | +66,666 | 1.66% | ✗ | $1000K |